Clinical Trials Browser

Phase 2/3 × Interventional × Hypertension × Clear all

NCT01803711 2017-12-27

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

Phase 2/3 Terminated

6 enrolled 4 charts

Cardiovascular Diseases, Depression, Depressive Disorder, Major, Diabetes Mellitus, Hypertension, Neoplasms

NCT02072330 2014-02-26

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Phase 2/3 Completed

Hypertension, Lymphoma, Follicular